We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

228 hedge funds and large institutions have $3.63B invested in Amicus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 95 increasing their positions, 66 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

45% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $9.83M

44% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 66

6% more funds holding

Funds holding: 216 → 228 (+12)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

3.95% less ownership

Funds ownership: 107.98% → 104.03% (-4%)

6% less capital invested

Capital invested by funds: $3.86B → $3.63B (-$224M)

Holders
228
Holders Change
+12
Holders Change %
+5.56%
% of All Funds
3.62%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
33
Increased
95
Reduced
66
Closed
20
Calls
$14.3M
Puts
$9.83M
Net Calls
+$4.46M
Net Calls Change
-$2.09M

Top Buyers

Rank Fund Capital Flow
1
William Blair Investment Management
William Blair Investment Management
Illinois
+$104M
2
Victory Capital Management
Victory Capital Management
Texas
+$30.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.04M
4
American Century Companies
American Century Companies
Missouri
+$5.54M
5
N
Nuveen
North Carolina
+$5.5M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$78.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$78.1M
3
RG
Redmile Group
California
-$33.8M
4
Morgan Stanley
Morgan Stanley
New York
-$29.8M
5
O
OrbiMed
New York
-$23.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
126
Oppenheimer Asset Management
New York
$718K -$2.58K -200 -0.3%
DT
127
Diversified Trust
Tennessee
$706K +$233K +18,049 +45%
ProShare Advisors
128
ProShare Advisors
Maryland
$671K +$4.09K +317 +0.6%
JFG
129
Jefferies Financial Group
New York
$654K -$497K -38,512 -42%
Franklin Resources
130
Franklin Resources
California
$653K +$27.9K +2,163 +4%
SCA
131
Snowden Capital Advisors
New York
$652K -$57.4K -4,452 -8%
Handelsbanken Fonder
132
Handelsbanken Fonder
Sweden
$582K +$32.3K +2,500 +6%
Walleye Trading
133
Walleye Trading
New York
$565K +$600K +46,474 New
Brown Advisory
134
Brown Advisory
Maryland
$559K +$158K +12,285 +36%
GCM
135
Graham Capital Management
Connecticut
$556K +$589K +45,685 New
GS
136
GTS Securities
New York
$534K +$431K +33,389 +317%
AB
137
Amalgamated Bank
New York
$524K +$7.77K +602 +1%
HC
138
Henshaw Capital
Massachusetts
$523K +$201K +15,619 +57%
Two Sigma Investments
139
Two Sigma Investments
New York
$518K -$74.5K -5,778 -12%
ACM
140
Aquatic Capital Management
Illinois
$516K +$547K +42,400 New
Zurich Cantonal Bank
141
Zurich Cantonal Bank
Switzerland
$515K +$58.2K +4,508 +12%
N
142
Natixis
France
$482K +$511K +39,600 +79,200%
Public Employees Retirement Association of Colorado
143
Public Employees Retirement Association of Colorado
Colorado
$463K -$20.1K -1,560 -4%
Citadel Advisors
144
Citadel Advisors
Florida
$442K +$407K +31,557 +658%
EFM
145
E Fund Management
China
$442K +$19.5K +1,510 +4%
William Blair & Company
146
William Blair & Company
Illinois
$431K +$457K +35,454 New
SEC
147
Seven Eight Capital
New York
$414K -$381K -29,538 -46%
Mariner
148
Mariner
Kansas
$399K -$24.1K -1,868 -5%
AIM
149
Aigen Investment Management
New York
$385K +$409K +31,695 New
Simplex Trading
150
Simplex Trading
Illinois
$380K +$404K +31,319 New
4 5
6
7 8

FOLD Hedge Fund Activity: Q3 2023 in Review

228 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2023, worth a combined $3.63B — down 5.8% from $3.86B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new FOLD positions and 20 closed out — a net gain of 13 holders — while 95 added to existing stakes and 66 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $104M. The largest seller was Deutsche Bank, cutting an estimated $78.8M.

  • 228 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2023, up from 216 in Q2 2023.
  • Funds reported $3.63B of Amicus Therapeutics stock for Q3 2023, down 5.8% quarter-over-quarter.
  • 33 funds opened new Amicus Therapeutics positions in Q3 2023 and 20 closed out, a net change of +13 holders.
  • The largest Amicus Therapeutics buyer in Q3 2023 was William Blair Investment Management, an estimated $104M added.
  • The largest Amicus Therapeutics seller in Q3 2023 was Deutsche Bank, an estimated $78.8M sold.

Based on aggregated 13F filings for Q3 2023.